Jeffrey B. Mirviss Boston Scientific Corp (BSX) insider trading activity

Jeffrey B. Mirviss is EVP&Pres, Periph Intervent of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 25,766 shares of BSX, which is worth approximately $2.6 Million. The most recent transaction as insider was on Feb 25, 2025, when has been sold 2,688 shares (Common Stock) at a price of $104.0 per share, resulting in proceeds of $279,552. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K

8.05% 3M change

64.51% 12M change

Total Value Held $2.6 Million

Jeffrey B. Mirviss Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 25 2025	SELL Open market or private sale	$279,552 $104.0 p/Share	2,688 Reduced 9.45%	25,766 Common Stock
Feb 24 2025	SELL Open market or private sale	$487,368 $104.25 p/Share	4,675 Reduced 14.11%	28,454 Common Stock
Feb 19 2025	SELL Open market or private sale	$159,078 $105.35 p/Share	1,510 Reduced 4.36%	33,129 Common Stock
Feb 17 2025	SELL Payment of exercise price or tax liability	$161,393 $106.11 p/Share	1,521 Reduced 4.21%	34,639 Common Stock
Feb 17 2025	BUY Exercise of conversion of derivative security	-	3,334 Added 8.44%	36,160 Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$143,779 $106.11 p/Share	1,355 Reduced 3.96%	32,826 Common Stock
Feb 16 2025	BUY Exercise of conversion of derivative security	-	2,970 Added 7.99%	34,181 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$134,335 $106.11 p/Share	1,266 Reduced 3.9%	31,211 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	-	2,776 Added 7.87%	32,477 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$91,808 $105.77 p/Share	868 Reduced 2.84%	29,701 Common Stock
Feb 12 2025	SELL Open market or private sale	$1,368,091 $105.06 p/Share	13,022 Reduced 31.4%	28,454 Common Stock
Feb 12 2025	BUY Exercise of conversion of derivative security	-	2,115 Added 6.47%	30,569 Common Stock
Feb 11 2025	SELL Payment of exercise price or tax liability	$1,138,013 $105.98 p/Share	10,738 Reduced 20.57%	41,476 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	23,760 Added 31.27%	52,214 Common Stock
Jan 03 2025	SELL Open market or private sale	$642,678 $89.86 p/Share	7,152 Reduced 20.09%	28,454 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$292,790 $89.32 p/Share	3,278 Reduced 8.43%	35,606 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	10,430 Added 21.15%	38,884 Common Stock
May 29 2024	SELL Open market or private sale	$4,791,530 $75.1 p/Share	63,802 Reduced 69.48%	28,022 Common Stock
May 29 2024	BUY Exercise of conversion of derivative security	$582,110 $17.26 p/Share	33,726 Added 26.86%	91,824 Common Stock
Mar 18 2024	SELL Open market or private sale	$963,923 $66.45 p/Share	14,506 Reduced 19.98%	58,098 Common Stock
Feb 21 2024	SELL Open market or private sale	$329,096 $66.35 p/Share	4,960 Reduced 6.39%	72,604 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$84,578 $65.82 p/Share	1,285 Reduced 1.63%	77,564 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	2,817 Added 3.45%	78,849 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$100,046 $65.82 p/Share	1,520 Reduced 1.96%	76,032 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	3,333 Added 4.12%	77,552 Common Stock

JBM

Jeffrey B. Mirviss

EVP&Pres, Periph Intervent

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account